Dışkıda Kan
Özet
Dışkıda kan saptanması, kolorektal kanser taraması veya diğer gastrointestinal şikayetlerin değerlendirilmesinde kritik bir bulgudur. Bu durum, gözle görülmeyen (gizli) veya aşikar kanama şeklinde ortaya çıkabilir. Dışkıda gizli kan tespiti için Fekal İmmünokimyasal Test (FİT) ve Guaiac tabanlı testler kullanılır; FİT, diyete bağlı kalmaması ve yalnızca insan hemoglobinine duyarlı olması nedeniyle daha yüksek hassasiyet sunar. Tarama çalışmaları, bu testlerin kolorektal kanser kaynaklı mortaliteyi önemli ölçüde azalttığını kanıtlamıştır. Testin pozitif çıkması durumunda, kanamanın nedenini belirlemek için kolonoskopi ve üst endoskopi temel tanı yöntemleridir. Standart endoskopilerin yetersiz kaldığı "şüpheli ince bağırsak kanaması" durumlarında ise kablosuz video kapsül endoskopisi, itme enteroskopisi veya derin ince bağırsak enteroskopisi gibi ileri tekniklere başvurulur. Kanamanın etiyolojisinde divertiküloz, anjiyodisplazi, kolit, polipler, kanser ve hemoroid gibi çok çeşitli faktörler yer almaktadır. Özellikle yaşlı hastalarda vasküler nedenler ve divertiküller ön plandayken, gençlerde inflamatuar bağırsak hastalıkları daha sık görülür. Sonuç olarak, dışkıda kan saptanan hastalarda multidisipliner bir yaklaşımla kanama odağının netleştirilmesi ve nedene yönelik etkin bir tedavi planının sunulması hayati önem taşımaktadır.
The detection of blood in the stool is a critical finding in colorectal cancer screening or the evaluation of other gastrointestinal complaints. This condition can present as occult (hidden) or overt bleeding. For occult blood detection, Fecal Immunochemical Test (FIT) and Guaiac-based tests are utilized; FIT offers higher sensitivity as it does not require dietary restrictions and is specifically sensitive to human hemoglobin. Screening studies have proven that these tests significantly reduce colorectal cancer-related mortality. If a test result is positive, colonoscopy and upper endoscopy are the primary diagnostic methods to determine the cause of bleeding. In cases of "suspected small bowel bleeding" where standard endoscopies are insufficient, advanced techniques such as wireless video capsule endoscopy, push enteroscopy, or deep small bowel enteroscopy are employed. The etiology of bleeding includes a wide range of factors such as diverticulosis, angiodysplasia, colitis, polyps, cancer, and hemorrhoids. While vascular causes and diverticula are more prominent in elderly patients, inflammatory bowel diseases are more common in younger individuals. Consequently, it is of vital importance to clarify the source of bleeding through a multidisciplinary approach and provide an effective, cause-oriented treatment plan for patients with blood detected in their stool.
Referanslar
Brenner H, Tao S, Haug U Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA. 2010;304(22):2513.
Bujanda L, LanasÁ, Quintero E, Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test. Mayo Clin Proc. 2013;88(7):683. Epub 2013 Jun 7.
Brenner H, Calderazzo S, Seufferlein T, et al. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial. JAMA 2019; 321:1686.
Robertson DJ, Lee JK, Boland CR, et al. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2017; 112:37.
Park MJ, Choi KS, Lee YK, et al. A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program. Scand J Gastroenterol 2012; 47:461.
van Rossum LG, van Rijn AF, van Oijen MG, et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009; 125:746.
Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastrointest Endosc 2017; 85:2.
Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59:62.
Young GP, Symonds EL, Allison JE, et al. Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci 2015; 60:609.
Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. JAMA 2016; 315:2595.
Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014; 160:171.
Hassan C, Giorgi Rossi P, Camilloni L, et al. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther 2012; 36:929.
Wong MC, Ching JY, Chan VC, et al. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens. Clin Gastroenterol Hepatol 2015; 13:1472.
Selby K, Jensen CD, Lee JK, et al. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med 2018; 169:439.
Zorzi M, Hassan C, Capodaglio G, et al. Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study. Ann Intern Med 2018; 169:602.
van Roon AH, Goede SL, van Ballegooijen M, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 2013; 62:409.
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58:130.
Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149:638.
Pignone M, Campbell MK, Carr C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 2001; 4:150.
Jaffe RM, Kasten B, Young DS. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975; 83:824.
Sawhney MS, McDougall H, Nelson DB. Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci 2010; 55:1637.
Sox HC. Office-based testing for fecal occult blood: do only in case of emergency. Ann Intern Med 2005; 142:146.
Duffy MJ, van Rossum LG, van Turenhout ST, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011; 128:3.
Holme Ø, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013; :CD009259.
Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369:1106.
Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 1997; 89:1440.
Raju GS, Gerson L, Das A, et al. American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Gastroenterology 2007; 133:1694.
Bull-Henry K, Al-Kawas FH. Evaluation of occult gastrointestinal bleeding. Am Fam Physician 2013; 87:430.
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58:130.
Bini EJ, Rajapaksa RC, Valdes MT. Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy? Am J Med 1999; 106:613.
Sawhney MS, McDougall H, Nelson DB. Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci 2010; 55:1637.
Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA 2010; 304:2513.
Zwas FR, Lyon DT. Occult GI bleeding in the alcoholic. Am J Gastroenterol 1996; 91:551.
Bini EJ, Micale PL, Weinshel EH. Evaluation of the gastrointestinal tract in premenopausal women with iron deficiency anemia. Am J Med 1998; 105:281.
Vannella L, Aloe Spiriti MA, Cozza G, et al. Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia. Aliment Pharmacol Ther 2008; 28:422.
Zaman A, Katon RM. Push enteroscopy for obscure gastrointestinal bleeding yields a high incidence of proximal lesions within reach of a standard endoscope. Gastrointest Endosc 1998; 47:372.
Descamps C, Schmit A, Van Gossum A. "Missed" upper gastrointestinal tract lesions may explain "occult" bleeding. Endoscopy 1999; 31:452.
Chak A, Cooper GS, Canto MI, et al. Enteroscopy for the initial evaluation of iron deficiency. Gastrointest Endosc 1998; 47:144.
Lin S, Branch MS, Shetzline M. The importance of indication in the diagnostic value of push enteroscopy. Endoscopy 2003; 35:315.
Vlachogiannakos J, Papaxoinis K, Viazis N, et al. Bleeding lesions within reach of conventional endoscopy in capsule endoscopy examinations for obscure gastrointestinal bleeding: is repeating endoscopy economically feasible? Dig Dis Sci 2011; 56:1763.
de Leusse A, Vahedi K, Edery J, et al. Capsule endoscopy or push enteroscopy for first-line exploration of obscure gastrointestinal bleeding? Gastroenterology 2007; 132:855.
Laine L, Sahota A, Shah A. Does capsule endoscopy improve outcomes in obscure gastrointestinal bleeding? Randomized trial versus dedicated small bowel radiography. Gastroenterology 2010; 138:1673.
Hartmann D, Schmidt H, Bolz G, et al. A prospective two-center study comparing wireless capsule endoscopy with intraoperative enteroscopy in patients with obscure GI bleeding. Gastrointest Endosc 2005; 61:826.
Singh A, Marshall C, Chaudhuri B, et al. Timing of video capsule endoscopy relative to overt obscure GI bleeding: implications from a retrospective study. Gastrointest Endosc 2013; 77:761.
Kobayashi Y, Watabe H, Yamada A, et al. Impact of fecal occult blood on obscure gastrointestinal bleeding: observational study. World J Gastroenterol 2015; 21:326.
Min YW, Kim JS, Jeon SW, et al. Long-term outcome of capsule endoscopy in obscure gastrointestinal bleeding: a nationwide analysis. Endoscopy 2014; 46:59.
Svarta S, Segal B, Law J, et al. Diagnostic yield of repeat capsule endoscopy and the effect on subsequent patient management. Can J Gastroenterol 2010; 24:441.
Cave DR, Fleischer DE, Leighton JA, et al. A multicenter randomized comparison of the Endocapsule and the Pillcam SB. Gastrointest Endosc 2008; 68:487.
Shinozaki S, Yamamoto H, Yano T, et al. Long-term outcome of patients with obscure gastrointestinal bleeding investigated by double-balloon endoscopy. Clin Gastroenterol Hepatol 2010; 8:151.
Gerson L, Kamal A. Cost-effectiveness analysis of management strategies for obscure GI bleeding. Gastrointest Endosc 2008; 68:920.
Ress AM, Benacci JC, Sarr MG. Efficacy of intraoperative enteroscopy in diagnosis and prevention of recurrent, occult gastrointestinal bleeding. Am J Surg 1992; 163:94.
Green J, Schlieve CR, Friedrich AK, et al. Approach to the Diagnostic Workup and Management of Small Bowel Lesions at a Tertiary Care Center. J Gastrointest Surg 2018; 22:1034.
Wang Z, Chen JQ, Liu JL, et al. CT enterography in obscure gastrointestinal bleeding: a systematic review and meta-analysis. J Med Imaging Radiat Oncol 2013; 57:263.
Lee SS, Oh TS, Kim HJ, et al. Obscure gastrointestinal bleeding: diagnostic performance of multidetector CT enterography. Radiology 2011; 259:739.
Lin S, Suhocki PV, Ludwig KA. Gastrointestinal bleeding in adult patients with Meckel's diverticulum: the role of technetium 99m pertechnetate scan. South Med J 2002; 95:1338.
Leung WK, Ho SS, Suen BY, et al. Capsule endoscopy or angiography in patients with acute overt obscure gastrointestinal bleeding: a prospective randomized study with long-term follow-up. Am J Gastroenterol 2012; 107:1370.
Strate LL. Lower GI bleeding: epidemiology and diagnosis. Gastroenterol Clin North Am 2005; 34:643.
Boley SJ, DiBiase A, Brandt LJ. Lower intestinal bleeding in the elderly. Am J Surg 1979; 137:57.
Korkis AM, McDougall CJ. Rectal bleeding in patients less than 50 years of age. Dig Dis Sci 1995; 40:1520.
Peery AF, Barrett PR, Park D, et al. A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology 2012; 142:266.
Parks TG. Post-mortem studies on the colon with special reference to diverticular disease. Proc R Soc Med 1968; 61:932.
Casarella WJ, Kanter IE, Seaman WB. Right-sided colonic diverticula as a cause of acute rectal hemorrhage. N Engl J Med 1972; 286:450.
Nagata N, Niikura R, Aoki T, et al. Impact of discontinuing non-steroidal antiinflammatory drugs on long-term recurrence in colonic diverticular bleeding. World J Gastroenterol 2015; 21:1292.
Aytac E, Stocchi L, Gorgun E. Risk of recurrence and long-term outcomes after colonic diverticular bleeding. Int J Colorectal Dis 2014; 29:373.
Foutch PG, Rex DK, Lieberman DA. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol 1995; 90:564.
Diggs NG, Holub JL, Lieberman DA, et al. Factors that contribute to blood loss in patients with colonic angiodysplasia from a population-based study. Clin Gastroenterol Hepatol 2011; 9:415.
Chavalitdhamrong D, Jensen DM, Kovacs TO, et al. Ischemic colitis as a cause of severe hematochezia: risk factors and outcomes compared with other colon diagnoses. Gastrointest Endosc 2011; 74:852.
Macrae FA, St John DJ. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82:891.
